Workshop Innovative funding strategies for translational research

Sorry, Access to this content is only open to registered participants.
If you are not registered yet, click HERE for more information how to register for PSWC2020


Bernard Munos, Founder InnoThink Center for Research in Biomedical Innovation and Denis DeBlois, Chair of the International Scientific Programme Commitee PSWC


The ecosystem supporting the translation of basic discoveries into clinical innovations has evolved dramatically in the past decades. And the rate of change is not slowing down. Increasingly, we see novel models of partnerships between academia, venture capital, private companies, patient organizations and governments. A better knowledge of this ecosystem is becoming a key skill. This workshop is for all pharmaceutical scientist interested in translational research. Participants will learn how current key models of partnership are set up to support the development of discoveries towards the clinic.


Collaborative models in drug R&D: the transformative changes ahead
Bernard Munos Senior Fellow, FasterCures

Leading academia across the valley of death
Steven Klein, VP B-D, IRICoR

Precompetitive research to improve the R&D landscape
Nadia Dubé, CQDM

How venture capital can help
Inès Holzbaur, Amorchem

Translating our research excellence into an industry of scale
Mounia Azzi, AdMare BioInnovations

General discussion

Learning Objectives

  1. What are the major trends and current opportunities in translational research?
  2. How to compare among various types of possible partnerships to support translational research?
  3. How can pharmaceutical scientists use this knowledge to improve the impact of their research?


Target audience

Academic researchers, industry scientists and clinicians.

Scientists with a project that may benefit from translational research support.

Please register


Certificate of attendance for all (delivered by FIP)